Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Placebo-Controlled, Flexible-Dose Clinical Trial.
Author | |
---|---|
Abstract |
:
Binge-eating disorder (BED) is the most prevalent eating disorder; however, few evidence-based treatments are available. The aim of this study was to evaluate the efficacy and safety of dasotraline, a novel dopamine and norepinephrine reuptake inhibitor, in adults with BED. |
Year of Publication |
:
2020
|
Journal |
:
The Journal of clinical psychiatry
|
Volume |
:
81
|
Issue |
:
5
|
Date Published |
:
2020
|
ISSN Number |
:
0160-6689
|
URL |
:
http://www.psychiatrist.com/JCP/article/Pages/efficacy-and-safety-of-dasotraline-in-adults-with-binge-eating-disorder.aspx
|
DOI |
:
10.4088/JCP.19m13068
|
Short Title |
:
J Clin Psychiatry
|
Download citation |